BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 9716183)

  • 1. Activation of the mitogen-activated protein kinase pathway in U937 leukemic cells induces phosphorylation of the amino terminus of the TATA-binding protein.
    Biggs JR; Ahn NG; Kraft AS
    Cell Growth Differ; 1998 Aug; 9(8):667-76. PubMed ID: 9716183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells.
    Franklin CC; Kraft AS
    J Biol Chem; 1997 Jul; 272(27):16917-23. PubMed ID: 9202001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
    Franklin CC; Kraft AS
    Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells.
    Whitehurst CE; Geppert TD
    J Immunol; 1996 Feb; 156(3):1020-9. PubMed ID: 8557975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dominant role for the Raf-MEK pathway in forskolin, 12-O-tetradecanoyl-phorbol acetate, and platelet-derived growth factor-induced CREB (cAMP-responsive element-binding protein) activation, uncoupled from serine 133 phosphorylation in NIH 3T3 cells.
    Seternes OM; Johansen B; Moens U
    Mol Endocrinol; 1999 Jul; 13(7):1071-83. PubMed ID: 10406459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitogen-activated protein kinase pathway inhibits ceramide-induced terminal differentiation of a human monoblastic leukemia cell line, U937.
    Ragg SJ; Kaga S; Berg KA; Ochi A
    J Immunol; 1998 Aug; 161(3):1390-8. PubMed ID: 9686602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer.
    Durham PL; Russo AF
    Mol Endocrinol; 1998 Jul; 12(7):1002-9. PubMed ID: 9658404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
    Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
    Bardwell AJ; Abdollahi M; Bardwell L
    Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation.
    Chu Y; Solski PA; Khosravi-Far R; Der CJ; Kelly K
    J Biol Chem; 1996 Mar; 271(11):6497-501. PubMed ID: 8626452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged activation of the mitogen-activated protein kinase pathway is required for macrophage-like differentiation of a human myeloid leukemic cell line.
    Hu X; Moscinski LC; Valkov NI; Fisher AB; Hill BJ; Zuckerman KS
    Cell Growth Differ; 2000 Apr; 11(4):191-200. PubMed ID: 10775036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mek1 phosphorylation site mutants activate Raf-1 in NIH 3T3 cells.
    Alessandrini A; Greulich H; Huang W; Erikson RL
    J Biol Chem; 1996 Dec; 271(49):31612-8. PubMed ID: 8940180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-induced c-Jun N-terminal kinase activation is negatively regulated by protein kinase C delta.
    Morino K; Maegawa H; Fujita T; Takahara N; Egawa K; Kashiwagi A; Kikkawa R
    Endocrinology; 2001 Jun; 142(6):2669-76. PubMed ID: 11356718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
    Okumura K; Shirasawa S; Nishioka M; Sasazuki T
    Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
    Vrana JA; Saunders AM; Chellappan SP; Grant S
    Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes.
    Liang Q; Wiese RJ; Bueno OF; Dai YS; Markham BE; Molkentin JD
    Mol Cell Biol; 2001 Nov; 21(21):7460-9. PubMed ID: 11585926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin regulation of mitogen-activated protein kinase kinase (MEK), mitogen-activated protein kinase and casein kinase in the cell nucleus: a possible role in the regulation of gene expression.
    Kim SJ; Kahn CR
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):621-7. PubMed ID: 9169593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
    Hutter D; Chen P; Barnes J; Liu Y
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrin and phorbol 12-myristate 13-acetate regulate the human histidine decarboxylase promoter through Raf-dependent activation of extracellular signal-regulated kinase-related signaling pathways in gastric cancer cells.
    Höcker M; Henihan RJ; Rosewicz S; Riecken EO; Zhang Z; Koh TJ; Wang TC
    J Biol Chem; 1997 Oct; 272(43):27015-24. PubMed ID: 9341140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delay in serum stimulation of Erk activity caused by oncogenic transformation.
    Greulich H; Reichman C; Hanafusa H
    Oncogene; 1996 Apr; 12(8):1689-95. PubMed ID: 8622889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.